日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The Landscape of Ferroptosis-Related Gene Signatures as Molecular Stratification in Triple-Negative Breast Cancer

铁死亡相关基因特征在三阴性乳腺癌分子分层中的作用

Buta, Marko; Jeftic, Nikola; Besu, Irina; Raketic, Jovan; Markovic, Ivan; Djuric, Ana; Petrovic, Nina; Srdic-Rajic, Tatjana

Pioneering first-in-class HDAC-ROCK inhibitors as potential multitarget anticancer agents.

开创性的首创 HDAC-ROCK 抑制剂作为潜在的多靶点抗癌药物

Beljkas Milan, Ruzic Dusan, Djuric Ana, Vuletic Ana, Tchiehe Guilaine Nchugoua, Jallet Corinne, Cadet-Daniel Véronique, Arimondo Paola B, Santibanez Juan F, Srdic-Rajic Tatjana, Nikolic Katarina, Oljacic Slavica, Petkovic Milos

Development of Novel ROCK Inhibitors via 3D-QSAR and Molecular Docking Studies: A Framework for Multi-Target Drug Design

通过三维定量构效关系(3D-QSAR)和分子对接研究开发新型ROCK抑制剂:多靶点药物设计的框架

Beljkas, Milan; Petkovic, Milos; Vuletic, Ana; Djuric, Ana; Santibanez, Juan Francisco; Srdic-Rajic, Tatjana; Nikolic, Katarina; Oljacic, Slavica

Author Correction: Iscador Qu inhibits doxorubicin-induced senescence of MCF7 cells

作者更正:Iscador Qu抑制阿霉素诱导的MCF7细胞衰老

Srdic-Rajic, Tatjana; Santibañez, Juan F; Kanjer, Ksenija; Tisma-Miletic, Nevena; Cavic, Milena; Galun, Daniel; Jevric, Marko; Kardum, Nevena; Konic-Ristic, Aleksandra; Zoranovic, Tamara

Targeted therapy and personalized medicine in hepatocellular carcinoma: drug resistance, mechanisms, and treatment strategies

肝细胞癌的靶向治疗和个体化医疗:耐药性、机制和治疗策略

Galun, Danijel; Srdic-Rajic, Tatjana; Bogdanovic, Aleksandar; Loncar, Zlatibor; Zuvela, Marinko

Biological evaluation of transdichloridoplatinum(II) complexes with 3- and 4-acetylpyridine in comparison to cisplatin

对反式二氯铂(II)与3-和4-乙酰吡啶形成的配合物与顺铂的生物学评价

Filipovic, Lana; Arandelovic, Sandra; Gligorijevic, Nevenka; Krivokuca, Ana; Jankovic, Radmila; Srdic-Rajic, Tatjana; Rakic, Gordana; Tesic, Zivoslav; Radulovic, Sinisa